Skip to main content
. 2020 Oct 1;52(1):317–324. doi: 10.1016/j.ijnurstu.2014.06.008

Table 2.

PPVa uptake and reasons for not receiving PPV at 1-week.

Intervention (n = 1251) Control (n = 1266) ARRb (95% CI)
Computer-recorded PPV uptake n (%) 716 (57.2) 609 (48.1) 1.2 (1.06, 1.37)
Awareness of PPV at 3-month, n (%) 803 (64.2) 734 (58.0) 0.86 (0.69, 1.07)
Reason(s) for not receiving PPV at 1-week Intervention (n = 448) Control (n = 532) p-Value
No need to receive PPV 130 (29.0) 188 (35.3) 0.040
Had received all necessary vaccinations 27 (6.0) 62 (11.7) 0.002
Too expensive 1 (0.2) 2 (0.4) 1.000
Don’t know where to receive vaccination 37 (8.3) 75 (14.1) 0.005
Sick/not feeling well 28 (6.3) 35 (6.6) 0.896
Would have surgery soon 8 (1.8) 8 (1.5) 0.803
No time 5 (1.1) 1 (0.2) 0.099
No one mentioned abut PPV at medical appointment 25 (5.6) 30 (5.6) 1.000
Have PPV later 11 (2.5) 7 (1.3) 0.234
Doctor did not recommend 24 (5.4) 17 (3.2) 0.109
Don’t want to receive PPV 15 (3.3) 2 (0.4) <0.001
Forgot to follow-up 12 (2.7) 12 (2.3) 0.684
Afraid of side effects of PPV/injection 113 (25.2) 68 (12.8) <0.001
Others 12 (2.7) 25 (4.7) 0.129
a

PPV, pneumococcal polysaccharide vaccine.

b

Relative risk (RR) for Clinical Management System-recorded PPV uptake associated with the intervention adjusted for the effects of clustering, clinic, patient's educational level, whether have vaccination in the past 12 months and whether was aware of PPV at baseline.